Goldman Sachs Downgrades U.S. Large Cap Biotech Shares To Neutral
BBH Hot Sheet
Rating Summary:0 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 7 | New: 23
Goldman Sachs Downgrades U.S. Large Cap Biotech Shares To Neutral.
Related ETF: Biotech HOLDRs (NYSE: BBH).
Related ETF: Biotech HOLDRs (NYSE: BBH).
You May Also Be Interested In
- Goldman Sachs Downgrades Raytheon (RTN) to Sell; Risk To Back-End Loaded 2012
- Goldman Sachs Starts MRC Global (MRC) at Neutral
- Goldman Sachs Defends J.P. Morgan (JPM); 'Down But Not Out'
Create E-mail Alert Related Categories
DowngradesRelated Entities
Goldman SachsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
